Posted in #HCSM

How Online Forums Can Help Patient-Centered Drug Development: Why Should We Treat Patient-generated Online Content Seriously

Thoughts From Broad Street

In the August issue of New England Journal of Medicine (NEJM), Dr. Ethan Basch, an oncologist at Memorial Sloan-Kettering Cancer Center wrote an article titled Toward Patient-Centered Drug Development in Oncology. Dr. Basch pointed out there is a lack of patient perspective in oncology drug development—when asked about symptom information of a treatment by patients, oncologists are often not able to provide it because such information is not included in the FDA-approved label. Dr. Basch noted that information about patient experience, if ever gathered in a pivotal clinical trial, is mainly through questionnaires focused on health-related quality of life rather than being included in the protocol-specified hypotheses and analytic or statistical plans. However, things might soon change– the FDA recently issued guidance on the use of patient-reported outcomes (PROs) in drug development, which may encourage the pharmaceutical industry to include the measurement of PROs in future drug development.

View original post 510 more words

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s